2018
DOI: 10.1210/en.2018-00671
|View full text |Cite
|
Sign up to set email alerts
|

Selective glucocorticoid receptor modulation prevents and reverses non-alcoholic fatty liver disease in male mice

Abstract: at the modification stage), and do not reflect editorial changes. No corrections/changes to the PDF manuscripts are accepted. Accordingly, there likely will be differences between the Advance Article manuscripts and the final, typeset articles. The manuscripts remain listed on the Advance Article page until the final, typeset articles are posted. At that point, the manuscripts are removed from the Advance Article page. DISCLAIMER: These manuscripts are provided "as is" without warranty of any kind, either expr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
31
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 31 publications
(32 citation statements)
references
References 49 publications
1
31
0
Order By: Relevance
“…In addition, synthetic modulators of glucocorticoid receptor can attenuate obesity and inflammation and reverse fatty liver in experimental animals. 129,130 Much further work is required for a better understanding of the role of the 11β-HSD1 and 11β-HSD2 in glucocorticoid action.…”
Section: Importance Of Cortisol and Cortisone Interconversion To Glucmentioning
confidence: 99%
“…In addition, synthetic modulators of glucocorticoid receptor can attenuate obesity and inflammation and reverse fatty liver in experimental animals. 129,130 Much further work is required for a better understanding of the role of the 11β-HSD1 and 11β-HSD2 in glucocorticoid action.…”
Section: Importance Of Cortisol and Cortisone Interconversion To Glucmentioning
confidence: 99%
“…The primary role of glucocorticoids in the liver is to regulate hepatic energy homeostasis and control hepatic influx and the efflux of lipids [30,31]. Moreover, both liver steatosis and fibrosis have been shown to be promoted by substantial glucocorticoid exposure and receptor antagonism [32]. In addition, glucocorticoids were found to be potent modulators of the IGF system, as they were able to reduce the local expression of IGF1 [33].…”
Section: Glucocorticoids Participate In Iugr Liver Metabolismmentioning
confidence: 99%
“…28 Corticosterone concentration was measured by ELISA according to the manufacturer's protocol (Corticosterone EIA, Immunodiagnostics). These samples were used to determine plasma concentrations of P1NP and TRAP using enzyme immunoassay kits (IDS) according to manufacturer's instructions.…”
Section: P1np Trap and Corticosterone Measurementsmentioning
confidence: 99%